Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
-
Trupanion Reports Second Quarter 2025 Results
-
Canterbury Park Holding Corporation Reports Second Quarter Results
-
Inseego Reports Second Quarter 2025 Financial Results
-
Century Aluminum Company Reports Second Quarter 2025 Results
-
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
-
BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
-
Bridger Aerospace Announces Strongest Second Quarter in Company History
-
ARMOUR Residential REIT, Inc. Announces Closing of Public Offering of 18,500,000 Shares of Common Stock
-
Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
-
SharpLink to Host Second Quarter 2025 Conference Call and Webcast on August 15, 2025 at 8:30 AM ET
-
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
-
Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results
-
Allbirds Reports Second Quarter 2025 Financial Results
-
INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes
-
Runway Growth Finance Corp. Reports Second Quarter 2025 Financial Results
-
NCS Multistage Holdings, Inc. to Participate in Upcoming Investor Conferences
-
Zymeworks Provides Corporate Update and Reports Second Quarter 2025 Financial Results
-
Full House Resorts Announces Second Quarter Results
-
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025
-
Regeneron Announces Investor Conference Presentations
-
Fidus Investment Corporation Announces Second Quarter 2025 Financial Results
-
Scientific Industries Completes Strategic Refocus and Secures Proceeds of $10 million to Accelerate Growth of Two Data-Driven Business Platforms; Divests Genie® Division to OHAUS Corporation’s affi
-
Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update
-
CarGurus Announces Second Quarter 2025 Results & Shares Plans to Wind Down CarOffer Transactions Business
-
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
PacBio Announces Second Quarter 2025 Financial Results
-
Flutter Entertainment: Q2 2025 Update
-
Commerce to Host Sell-side Analyst Q&A Session at Upcoming BigSummit
-
VAALCO Energy, Inc. Declares Third Quarter 2025 Dividend
-
Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC
-
Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth
-
The Joint Corp. Reports Second Quarter 2025 Financial Results
-
Rackspace Technology Reports Second Quarter 2025 Results
-
Tyson Foods Announces Quarterly Dividend and Increase in Authorization Under Share Repurchase Program
-
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
-
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
-
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
-
Kura Oncology Reports Second Quarter 2025 Financial Results
-
Omada Health Reports Second Quarter 2025 Results
-
IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery
-
Fox Factory Holding Corp. Reports Second Quarter Fiscal 2025 Financial Results
-
Concentrix to Present at Upcoming Investor Conferences
-
Portman Ridge Finance Corporation Announces Second Quarter 2025 Financial Results
-
Synaptics Reports Fourth Quarter and Full Year Fiscal 2025 Results
-
Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
-
AvePoint Announces Second Quarter 2025 Financial Results
-
Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results
